1472 results
Bicuspid aortic valves: where do we stand?
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to learn more about bicuspid aortic valves: understand patient selection for TAVI, explore sizing and valve selection, and discover the key procedural steps for TAVI in bicuspid AV.
Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.
Case-based challenging TAVI
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations.
Why durability matters: lifetime management considerations for supra-annular TAVR
26 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...
Contemporary procedural practice for TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.
Valve-in-valve TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.
TAVI and coronary artery disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis
24 Sep 2021
Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...
Reviewer
Reviewer
Planning for the Future: Lifetime Management Considerations for TAVI Patients
23 Sep 2021 – From PCR Tokyo Valves 2021
By establishing a constant parallel between the situation in the United States and that in Japan, based on data collected daily, Jeffrey Popma and Shinichi Shirai provide current insights into the use of the soft expanding supra-annular evolution platform. In particular, they address the question of which patient...
Optimizing TAVI Procedures: Is Cusp Overlap Standard of Care?
23 Sep 2021 – From PCR Tokyo Valves 2021
Based on the results of the Optimize PRO and OCEAN-TAVI studies, Yohei Ohno and Yusuke Watanabe explain the key principles of the cusp overlap technique, a novel technique to potentially reduce new onset conduction disturbance. The objectives of the cusp overlap technique being to Determine, Assess, Reduce, and...
My implantation technique to minimize PPI
20 Sep 2021 – From PCR Tokyo Valves 2021
Watch this interview of Lars Søndergaard to understand why cusp overlap view tends to take the fold on the traditional technique of the three-cusp view to reduce risk of conduction subnormality, especially in young patients. Since the approval of TAVI in Europe in 2007, there has...
PCR-TV: reducing permanent pacemaker implantation post-TAVR: tips & tricks
15 Sep 2021
In this video, Kuljit Singh, Anthony Camuglia and Ganesh Manoharan discuss both the Cusp overlap technique as a way to reduce permanent pacemaker implantation post transcatheter aortic valve replacement (TAVR) and the frame alignment technique to optimise TAV implantation.
Post-dilation from contralateral access site for nose cone entrapment during self-expandable transcatheter aortic valve implantation
07 Sep 2021
View this successful case with bail-out post-dilation for modifying nose cone entrapment due to stent frame infolding.
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
2021 ESC/EACTS Valvular Heart Disease Guidelines: interview with Alec Vahanian
29 Aug 2021
Mirvat Alasnag interviews Alec Vahanian on the Essentials of the 2021 ESC/EACTS Guidelines on Valvular Heart Diseases.
Author
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
PCRonline @ ESC Congress 2021: the interventional cardiology perspective!
21 Jul 2021
Make sure you stay up to date with what's new and hot in interventional cardiology at this year's #ESCCongress!
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement
09 Jul 2021
Read more about the Nordic Aortic Valve Intervention (NOTION) trial to compare clinical outcomes and durability of bioprosthetic aortic valves 8 years after TAVI and SAVR.
Reviewer
#2 - How can I minimise paravalvular leak for my TAVI patients?
29 Jun 2021
Watch this PCR Webinar with A. Latib, M. Reardon and L. Sondergaard
Discover the new Evolut™ PRO+ TAVI System
17 Jun 2021
New data from Optimize PRO interim analysis
From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.
